HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Survivorship and Long-Term Care
Survivorship and Long-Term Care
- Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers.
- Quality of Life: Addressing the long-term physical, psychological, and social effects of cancer.
- Rehabilitation: Physical therapy, occupational therapy, and return to work programs.
- Fertility Preservation: Options for cancer patients before, during, and after treatment.
Survivorship and long-term care are critical aspects of cancer research, focusing on the health and well-being of individuals who have completed cancer treatment. Research in this area explores how survivors manage physical, emotional, and social challenges that arise post-treatment. Studies show that many cancer survivors face long-term side effects, including fatigue, pain, and emotional stress, which can affect their quality of life. Innovations in personalized care plans and supportive therapies, such as mental health counseling and rehabilitation, aim to address these challenges. Ongoing research seeks to enhance survivorship outcomes, improve long-term care strategies, and ensure survivors lead fulfilling lives after cancer.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada Cancer Research 2026 Speakers
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar, UT MD Anderson Cancer Center, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada